Skip to main content
Top
Gepubliceerd in: Netherlands Heart Journal 4/2009

01-04-2009 | Special article

A historical perspective towards a non-invasive treatment for patients with atherosclerosis

Auteurs: W. Slijkhuis, W. Mali, Y. Appelman

Gepubliceerd in: Netherlands Heart Journal | Uitgave 4/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

The history of atherosclerosis and cardiovascular disease dates back to ancient times. From the teachings of Galen to the response-to-injury hypothesis of Russel Ross, we have now arrived at the concept of the vulnerable plaque. Next to the development of new treatment options for patients with atherosclerosis, also novel diagnostic imaging techniques have been developed to visualise the arterial wall and to characterise plaque composition. In this article the historical context of atherosclerosis and the attempts towards a noninvasive therapy for patients with atherosclerotic diseases are described. (Neth Heart J 2009;17: 140–5.)
Literatuur
1.
go back to reference Sternbach GL, Varon J, Fromm RE, Sicuro M, Baskett PJ. Galen and the origins of artificial ventilation, the arteries and the pulse. Resuscitation 2001;49:119–22. Sternbach GL, Varon J, Fromm RE, Sicuro M, Baskett PJ. Galen and the origins of artificial ventilation, the arteries and the pulse. Resuscitation 2001;49:119–22.
2.
go back to reference Silverman ME. William Harvey and the discovery of the circulation of blood. Clin Cardiol 1985;8:244–6. Silverman ME. William Harvey and the discovery of the circulation of blood. Clin Cardiol 1985;8:244–6.
3.
go back to reference Davies MK, Eollman A. Leonardo da Vinci (1452–1519). Heart 1996;76:464. Davies MK, Eollman A. Leonardo da Vinci (1452–1519). Heart 1996;76:464.
4.
go back to reference Khan IA, Mehta NJ. Initial historical descriptions of the angina pectoris. J Emerg Med 2002;22:295–8. Khan IA, Mehta NJ. Initial historical descriptions of the angina pectoris. J Emerg Med 2002;22:295–8.
5.
go back to reference Mayerl C, Lukasser M, Sedivy R, Niederegger H, Seiler R, Wick G. Atherosclerosis research from past to present–on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch 2006;449:96–103. Mayerl C, Lukasser M, Sedivy R, Niederegger H, Seiler R, Wick G. Atherosclerosis research from past to present–on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch 2006;449:96–103.
6.
go back to reference Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999;340:115–26. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999;340:115–26.
7.
go back to reference Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462–78. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462–78.
8.
go back to reference Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92:1355–74. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92:1355–74.
9.
go back to reference Lerakis S, Synetos A, Toutouzas K, Vavuranakis M, Tsiamis E, Stefanadis C. Imaging of the vulnerable plaque: noninvasive and invasive techniques. Am J Med Sci 2008;336:342–8. Lerakis S, Synetos A, Toutouzas K, Vavuranakis M, Tsiamis E, Stefanadis C. Imaging of the vulnerable plaque: noninvasive and invasive techniques. Am J Med Sci 2008;336:342–8.
10.
go back to reference Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007;356:2388–98. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007;356:2388–98.
11.
go back to reference Smith SC Jr., Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363–72. Smith SC Jr., Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363–72.
12.
go back to reference Beyar R. Controlling ischemic cardiovascular disease: from basic mechanisms to clinical management. Ann N Y Acad Sci 2008; 1123:232–6. Beyar R. Controlling ischemic cardiovascular disease: from basic mechanisms to clinical management. Ann N Y Acad Sci 2008; 1123:232–6.
13.
go back to reference Appelman YE, Piek JJ, Verhoofstad GG, Gijsbers GH, Van Gemert MJ. Tissue ablation and gas formation of two excimer laser systems: an in vitro evaluation on porcine aorta. Lasers Surg Med 1996;18:197–205. Appelman YE, Piek JJ, Verhoofstad GG, Gijsbers GH, Van Gemert MJ. Tissue ablation and gas formation of two excimer laser systems: an in vitro evaluation on porcine aorta. Lasers Surg Med 1996;18:197–205.
14.
go back to reference Zheng ZS, Li TM, Kambic H, Chen GH, Yu LQ, Cai SR, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983;29:599–603. Zheng ZS, Li TM, Kambic H, Chen GH, Yu LQ, Cai SR, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983;29:599–603.
15.
go back to reference Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999;33:1833–40. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999;33:1833–40.
16.
go back to reference Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 2000;94:31–5. Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 2000;94:31–5.
17.
go back to reference Masuda D, Nohara R, Hirai T, Kataoka K, Chen LG, Hosokawa R, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by (13)N-ammonia positron emission tomography. Eur Heart J 2001;22:1451–8. Masuda D, Nohara R, Hirai T, Kataoka K, Chen LG, Hosokawa R, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by (13)N-ammonia positron emission tomography. Eur Heart J 2001;22:1451–8.
18.
go back to reference Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: fiveyear follow-up study. Clin Cardiol 2000;23:254–8. Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: fiveyear follow-up study. Clin Cardiol 2000;23:254–8.
19.
go back to reference Gutersohn A, Gaspari G. Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. Circulation 2000;102:1–18. Gutersohn A, Gaspari G. Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. Circulation 2000;102:1–18.
20.
go back to reference Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055–61. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004;110:3055–61.
21.
go back to reference Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007;18:397–404. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, et al. Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 2007;18:397–404.
22.
go back to reference Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006;17:63–70. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, et al. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 2006;17:63–70.
23.
go back to reference Oron U, Yaakobi T, Oron A, Hayam G, Gepstein L, Rubin O et al. Attenuation of infarct size in rats and dogs after myocardial infarction by low-energy laser irradiation. Lasers Surg Med 2001; 28:204–11. Oron U, Yaakobi T, Oron A, Hayam G, Gepstein L, Rubin O et al. Attenuation of infarct size in rats and dogs after myocardial infarction by low-energy laser irradiation. Lasers Surg Med 2001; 28:204–11.
24.
go back to reference Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M et al. Lowlevel laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 2006;37:2620–4. Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M et al. Lowlevel laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 2006;37:2620–4.
25.
go back to reference DeTaboada L, Ilic S, Leichliter-Martha S, Oron U, Oron A, Streeter J. Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers Surg Med 2006;38:70–3. DeTaboada L, Ilic S, Leichliter-Martha S, Oron U, Oron A, Streeter J. Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers Surg Med 2006;38:70–3.
26.
go back to reference Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation 1992;86:1257–64. Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation 1992;86:1257–64.
27.
go back to reference Behrens S, Daffertshofer M, Spiegel D, Hennerici M. Lowfrequency, low-intensity ultrasound accelerates thrombolysis through the skull. Ultrasound Med Biol 1999;25:269–273. Behrens S, Daffertshofer M, Spiegel D, Hennerici M. Lowfrequency, low-intensity ultrasound accelerates thrombolysis through the skull. Ultrasound Med Biol 1999;25:269–273.
28.
go back to reference Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Varez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170–8. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Varez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170–8.
29.
go back to reference Eggers J, Konig IR, Koch B, Handler G, Seidel G. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke 2008; 39:1470–5. Eggers J, Konig IR, Koch B, Handler G, Seidel G. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke 2008; 39:1470–5.
30.
go back to reference Slikkerveer J, Dijkmans PA, Sieswerda GT, Doevendans PA, van Dijk AP, Verheugt FW, et al. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: Rationale and design of the Sonolysis study. Trials 2008;9:72. Slikkerveer J, Dijkmans PA, Sieswerda GT, Doevendans PA, van Dijk AP, Verheugt FW, et al. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: Rationale and design of the Sonolysis study. Trials 2008;9:72.
Metagegevens
Titel
A historical perspective towards a non-invasive treatment for patients with atherosclerosis
Auteurs
W. Slijkhuis
W. Mali
Y. Appelman
Publicatiedatum
01-04-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 4/2009
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086236

Andere artikelen Uitgave 4/2009

Netherlands Heart Journal 4/2009 Naar de uitgave